Posttest - Tumor Board Tuesday - January 11, 2022 (ID: i788-24)

1.Please list your first name, last name, and email:(Required.)
2.What is your specialty?(Required.)
3.Testing for ctDNA is commercially available for patients who have undergone resection of a colorectal cancer(Required.)
4.A 64 year old male with no comorbidities has undergone resection of a colorectal cancer. Pathology revealed a pT3, pN1b (3/24 LNs) moderately differentiated adenocarcinoma. Post-operative ctDNA was undetectable.

The guideline-recommended next approach for this patient is:
(Required.)